AAP
ATEX icon

Ardsley Advisory Partners’s Anterix ATEX Stock Holding History

Ardsley Advisory Partners’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-110,000
Closed -$4.2M – 156
2026
Q1 		$4.2M Buy
+110,000
New +$3.48M 0.54% 56

Other funds holding ATEX

KMC
Kirr Marbach & Co Columbus, Indiana $594M AUM 34% 1-Year Est. Return
FIC
FCG Investment Company Germantown, Tennessee $289M AUM
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Ardsley Advisory Partners's ATEX Position: Q2 2026 in Review

Ardsley Advisory Partners sold out of Anterix (ATEX) in Q2 2026, closing a stake of 110,000 shares — an estimated $4.2M sold.

Ardsley Advisory Partners first reported a position in ATEX in Q1 2026 and held it in 1 quarter. The position peaked at $4.2M in Q1 2026. 11 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Ardsley Advisory Partners reported no remaining Anterix position as of Q2 2026 after selling out during the quarter.
  • Ardsley Advisory Partners sold 110,000 Anterix shares in Q2 2026, an estimated $4.2M.
  • Ardsley Advisory Partners first reported a position in Anterix in Q1 2026 and held it in 1 quarter.
  • Ardsley Advisory Partners's Anterix position peaked at $4.2M in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Ardsley Advisory Partners's 13F filing for Q2 2026, filed 13 Jul 2026.